Up until about seven years ago, there was no way to identify lung cancer at an early stage. Individuals would often present to their physician with concerning symptoms like an unrelenting cough or unintentional weight loss, which could be signs of more advanced disease. Now, through the use of a simple CT scan, individuals deemed to be at risk for lung cancer can be identified at an early and curable stage.
After 22 years in the driver’s seat, Ginder will step down on December 2 from his rank as one of the longest-standing directors of a National Cancer Institute-designated cancer center.
Massey researchers awarded more than $2M to study links between tobacco retailers and smoke exposure in pregnant women and children
VCU Massey Cancer Center researchers Bernard Fuemmeler, Ph.D., M.P.H., and David Wheeler, M.P.H., Ph.D., received a $2.1 million R01 grant from the National Cancer Institute to examine the impact of tobacco retail outlets (TROs) and neighborhoods on maternal smoking during pregnancy as well as secondhand smoke exposure among children.
Mathematics isn’t usually what comes to mind when considering the disciplines involved in a cure for cancer, but Inho “Richard” Joh, Ph.D., intends to make a career out of it.
“One of the aspects of cancer biology that is severely behind other biological disciplines is in the use of mathematical modeling,” Joh said. “This is in part due to heterogeneity of tumor cells within the same tumor, between tumors and between tissues.”
Translational Research Initiative for Pain and Neuropathy (TRIPN) hosts inaugural research symposium
On Tuesday, November 5, the VCU Translational Research Initiative for Pain and Neuropathy (TRIPN) hosted its inaugural symposium showcasing the latest developments in pain and neuropathy research.